Corrigendum to "Successful steroid pulse therapy for brain lesion caused by Shiga toxin 2 in rabbits" [Microb Pathog 46 (2009) 179-84] (DOI:10.1016/j.micpath.2009.01.005);Successful steroid pulse therapy for brain lesion caused by Shiga toxin 2 in rabbits

Microbial Pathogenesis

Volumn 46, Issue 4, 2009, Pages 179-184

  Fujii, Jun ^a   Kinoshita, Yoshimasa ^b   Matsukawa, Akihiro ^c   Villanueva, Sharon Y A M ^a   Yutsudo, Takashi ^d   Yoshida, Shin ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Munakata Suikokai General Hospital   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d SHIONOGI AND CO LTD   (Japan)

Author keywords

Brain; MRI; O157; Pulse therapy; Steroid; Stx2

Indexed keywords

BETAMETHASONE; BETAMETHASONE SODIUM PHOSPHATE; GADOLINIUM PENTETATE MEGLUMINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; VEROTOXIN 1; VEROTOXIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN EDEMA; CONTROLLED STUDY; DRUG PULSE THERAPY; IMAGE ENHANCEMENT; MALE; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ORYCTOLAGUS CUNICULUS;

EID: 62749156383     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2009.04.001     Document Type: Erratum

References (32)

1. Fukushima H., Hashizume T., Morita Y., Tanaka J., Azuma K., Mizumoto Y., et al. Clinical experiences in Sakai City hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996. Pediatr Int 41 2 (1999) 213-217
2. Michino H., Araki K., Minami S., Takaya S., Sakai N., Miyazaki M., et al. Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol 150 8 (1999) 787-796 [see comments]
3. Rooney J.C., Anderson R.M., and Hopkins I.J. Clinical and pathological aspects of central nervous system involvement in the haemolytic uraemic syndrome. Aust Paediatr J 7 1 (1971) 28-33
4. Siegler R.L. The hemolytic uremic syndrome. Pediatr Clin North Am 42 6 (1995) 1505-1529
5. Upadhyaya K., Barwick K., Fishaut M., Kashgarian M., and Siegel N.J. The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics 65 1 (1980) 115-120
6. Fujii J., Kita T., Yoshida S., Takeda T., Kobayashi H., Tanaka N., et al. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun 62 8 (1994) 3447-3453
7. O'Brien A.D., and Holmes R.K. Shiga and Shiga-like toxins. Microbiol Rev 51 2 (1987) 206-220
8. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., and Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171 1-2 (1988) 45-50
9. Obrig T.G., Moran T.P., and Brown J.E. The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem J 244 2 (1987) 287-294
10. Lingwood C.A., Law H., Richardson S., Petric M., Brunton J.L., De G.S., et al. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 262 18 (1987) 8834-8839
11. Strockbine N.A., Jackson M.P., Sung L.M., Holmes R.K., and O'Brien A.D. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol 170 3 (1988) 1116-1122
12. Jackson M.P., Newland J.W., Holmes R.K., and O'Brien A.D. Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. Microb Pathog 2 2 (1987) 147-153
13. Louise C.B., and Obrig T.G. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 59 11 (1991) 4173-4179
14. Louise C.B., and Obrig T.G. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin and (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60 4 (1992) 1536-1543
15. Ramegowda B., Samuel J.E., and Tesh V.L. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J Infect Dis 180 4 (1999) 1205-1213
16. Fujii J., Wood K., Matsuda F., Carneiro-Filho B.A., Schlegel K.H., Yutsudo T., et al. Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein. Infect Immun 76 8 (2008) 3679-3689
17. Fujii J., Kinoshita Y., Kita T., Higure A., Takeda T., Tanaka N., et al. Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect Immun 64 12 (1996) 5053-5060
18. Steinborn M., Leiz S., Rudisser K., Griebel M., Harder T., and Hahn H. CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr Radiol 34 10 (2004) 805-810
19. Nakamura H., Takaba H., Inoue T., Saku Y., Saito F., Ibayashi S., et al. MRI findings of hemolytic uremic syndrome with encephalopathy: widespread symmetrical distribution. J Neuroimaging 13 1 (2003) 75-78
20. Yasuhara A., Araki A., Ochi A., and Kobayashi Y. Magnetic resonance imaging of brain lesions of a patient with hemolytic uremic syndrome following Escherichia coli O157 infection. Pediatr Int 42 3 (2000) 302-305
21. Fujii J., Kinoshita Y., Yamada Y., Yutsudo T., Kita T., Takeda T., et al. Neurotoxicity of intrathecal Shiga toxin 2 and protection by intrathecal injection of anti-Shiga toxin 2 antiserum in rabbits. Microb Pathog 25 3 (1998) 139-146
22. Fujii J., Kinoshita Y., Yutsudo T., Taniguchi H., Obrig T., and Yoshida S.I. Toxicity of Shiga toxin 1 in the central nervous system of rabbits. Infect Immun 69 10 (2001) 6545-6548
23. Takahashi K., Funata N., Ikuta F., and Sato S. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. J Neuroinflammation 5 (2008) 11
24. Tunkel A.R., and Scheld W.M. Pathogenesis and pathophysiology of bacterial meningitis. Annu Rev Med 44 (1993) 103-120
25. Hedley-Whyte E.T., and Hsu D.W. Effect of dexamethasone on blood-brain barrier in the normal mouse. Ann Neurol 19 4 (1986) 373-377
26. Chaplin E.R., Free R.G., and Goldstein G.W. Inhibition by steroids of the uptake of potassium by capillaries isolated from rat brain. Biochem Pharmacol 30 3 (1981) 241-245
27. Fujii J., and Yoshida S. Brain lesions in rabbits given an intravenous injection of verotoxin 2 and protection by anti-VT2 antibody. Nippon Rinsho 55 3 (1997) 736-740
28. Tesh V.L., Ramegowda B., and Samuel J.E. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun 62 11 (1994) 5085-5094
29. Fujii J., Matsui T., Heatherly D.P., Schlegel K.H., Lobo P.I., Yutsudo T., et al. Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect Immun 71 5 (2003) 2724-2735
30. Yutsudo T., Nakabayashi N., Hirayama T., and Takeda Y. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb Pathog 3 1 (1987) 21-30
31. Matsukawa A., Fukumoto T., Maeda T., Ohkawara S., and Yoshinaga M. Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health. Cytokine 9 5 (1997) 307-315
32. Matsui T., Sashihara S., Oh Y., and Waxman S.G. An orphan nuclear receptor, mROR alpha, and its spatial expression in adult mouse brain. Brain Res Mol Brain Res 33 2 (1995) 217-226